Uristat Ultra
NDC 63029-105, Phenazopyridine Hydrochloride, tablet, from Medtech Products Inc..
- Product NDC
- 63029-105
- Status
- Listed
- Labeler
- Medtech Products Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED DRUG OTHER
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63029-105 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PHENAZOPYRIDINE HYDROCHLORIDE99.5 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63029-105-12 | 63029010512 | 1 BLISTER PACK in 1 CARTON (63029-105-12) / 12 TABLET in 1 BLISTER PACK |
| 63029-105-30 | 63029010530 | 3 BLISTER PACK in 1 CARTON (63029-105-30) / 10 TABLET in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 63029-105 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63029-105 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63029-105. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.